Hamilton Lane Inc has a consensus price target of $152.22 based on the ratings of 10 analysts. The high is $190 issued by Morgan Stanley on November 11, 2024. The low is $111 issued by Wells Fargo on February 7, 2024. The 3 most-recent analyst ratings were released by Wells Fargo, Keefe, Bruyette & Woods, and Wells Fargo on March 20, 2025, February 5, 2025, and February 5, 2025, respectively. With an average price target of $163 between Wells Fargo, Keefe, Bruyette & Woods, and Wells Fargo, there's an implied 4.73% upside for Hamilton Lane Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
03/20/2025 | Buy Now | -2.34% | Wells Fargo | Michael Brown64% | $169 → $152 | Maintains | Equal-Weight | Get Alert |
02/05/2025 | Buy Now | 7.94% | Keefe, Bruyette & Woods | Kyle Voigt65% | $158 → $168 | Maintains | Market Perform | Get Alert |
02/05/2025 | Buy Now | 8.58% | Wells Fargo | Michael Brown64% | $163 → $169 | Maintains | Equal-Weight | Get Alert |
01/14/2025 | Buy Now | 4.73% | Wells Fargo | Michael Brown64% | $194 → $163 | Maintains | Equal-Weight | Get Alert |
01/13/2025 | Buy Now | 1.52% | Keefe, Bruyette & Woods | Kyle Voigt65% | $167 → $158 | Maintains | Market Perform | Get Alert |
01/06/2025 | Buy Now | -10.69% | Goldman Sachs | Alexander Blostein73% | → $139 | Downgrade | Neutral → Sell | Get Alert |
12/20/2024 | Buy Now | 7.3% | Keefe, Bruyette & Woods | Kyle Voigt65% | $215 → $167 | Maintains | Market Perform | Get Alert |
12/12/2024 | Buy Now | 24.65% | Wells Fargo | Michael Brown64% | $189 → $194 | Maintains | Equal-Weight | Get Alert |
11/11/2024 | Buy Now | 22.08% | Morgan Stanley | Michael Cyprys69% | $182 → $190 | Maintains | Equal-Weight | Get Alert |
11/07/2024 | Buy Now | 12.44% | JP Morgan | Ken Worthington71% | $134 → $175 | Maintains | Neutral | Get Alert |
11/07/2024 | Buy Now | 38.14% | Keefe, Bruyette & Woods | Kyle Voigt65% | $181 → $215 | Maintains | Market Perform | Get Alert |
10/22/2024 | Buy Now | 18.86% | UBS | Adam Beatty38% | $150 → $185 | Maintains | Neutral | Get Alert |
10/10/2024 | Buy Now | 16.94% | Morgan Stanley | Michael Cyprys69% | $140 → $182 | Maintains | Equal-Weight | Get Alert |
10/09/2024 | Buy Now | 9.23% | Wells Fargo | Michael Brown64% | $156 → $170 | Maintains | Equal-Weight | Get Alert |
10/03/2024 | Buy Now | -5.55% | Goldman Sachs | Alexander Blostein73% | $139 → $147 | Maintains | Neutral | Get Alert |
09/12/2024 | Buy Now | 0.23% | Wells Fargo | Michael Brown64% | → $156 | Initiates | → Equal-Weight | Get Alert |
08/21/2024 | Buy Now | -3.62% | UBS | Adam Beatty38% | $122 → $150 | Maintains | Neutral | Get Alert |
08/07/2024 | Buy Now | -13.9% | JP Morgan | Ken Worthington71% | $120 → $134 | Maintains | Neutral | Get Alert |
08/07/2024 | Buy Now | -6.84% | Keefe, Bruyette & Woods | Kyle Voigt65% | $135 → $145 | Maintains | Market Perform | Get Alert |
06/24/2024 | Buy Now | -21.61% | UBS | Adam Beatty38% | $120 → $122 | Maintains | Neutral | Get Alert |
05/24/2024 | Buy Now | -22.9% | JP Morgan | Ken Worthington71% | $115 → $120 | Maintains | Neutral | Get Alert |
05/24/2024 | Buy Now | -13.26% | Keefe, Bruyette & Woods | Michael Brown64% | $118 → $135 | Maintains | Market Perform | Get Alert |
04/12/2024 | Buy Now | -22.9% | UBS | Adam Beatty38% | $118 → $120 | Maintains | Neutral | Get Alert |
04/11/2024 | Buy Now | -26.11% | JP Morgan | Kenneth Worthington60% | → $115 | Downgrade | Overweight → Neutral | Get Alert |
02/07/2024 | Buy Now | -28.68% | Wells Fargo | Finian O'Shea64% | $106 → $111 | Maintains | Equal-Weight | Get Alert |
01/24/2024 | Buy Now | -19.04% | Morgan Stanley | Michael Cyprys69% | $102 → $126 | Maintains | Equal-Weight | Get Alert |
01/22/2024 | Buy Now | -31.89% | Wells Fargo | Finian O'Shea64% | $99 → $106 | Maintains | Equal-Weight | Get Alert |
01/11/2024 | Buy Now | — | Oppenheimer | Chris Kotowski83% | — | Downgrade | Outperform → Perform | Get Alert |
11/21/2023 | Buy Now | -34.46% | Morgan Stanley | Michael Cyprys69% | $95 → $102 | Maintains | Equal-Weight | Get Alert |
11/08/2023 | Buy Now | -33.82% | JP Morgan | Kenneth Worthington60% | $102 → $103 | Maintains | Overweight | Get Alert |
11/08/2023 | Buy Now | -42.82% | Wells Fargo | Finian O'Shea64% | $88 → $89 | Maintains | Equal-Weight | Get Alert |
10/18/2023 | Buy Now | -38.96% | Morgan Stanley | Michael Cyprys69% | $89 → $95 | Maintains | Equal-Weight | Get Alert |
08/03/2023 | Buy Now | -42.82% | Morgan Stanley | Michael Cyprys69% | $84 → $89 | Maintains | Equal-Weight | Get Alert |
08/03/2023 | Buy Now | -42.82% | Goldman Sachs | Alexander Blostein73% | $78 → $89 | Maintains | Neutral | Get Alert |
08/02/2023 | Buy Now | -34.46% | JP Morgan | Kenneth Worthington60% | $96 → $102 | Maintains | Overweight | Get Alert |
08/02/2023 | Buy Now | -42.82% | Goldman Sachs | Alexander Blostein73% | $78 → $89 | Maintains | Neutral | Get Alert |
08/02/2023 | Buy Now | -37.68% | Oppenheimer | Chris Kotowski83% | $93 → $97 | Maintains | Outperform | Get Alert |
08/02/2023 | Buy Now | -44.1% | Wells Fargo | Finian O'Shea64% | $77 → $87 | Maintains | Equal-Weight | Get Alert |
07/19/2023 | Buy Now | -43.46% | UBS | Adam Beatty38% | $75 → $88 | Maintains | Neutral | Get Alert |
07/18/2023 | Buy Now | -46.03% | Morgan Stanley | Michael Cyprys69% | $77 → $84 | Maintains | Equal-Weight | Get Alert |
07/11/2023 | Buy Now | -50.53% | Wells Fargo | Finian O'Shea64% | $71 → $77 | Maintains | Equal-Weight | Get Alert |
05/30/2023 | Buy Now | -50.53% | Morgan Stanley | Michael Cyprys69% | $78 → $77 | Maintains | Equal-Weight | Get Alert |
05/30/2023 | Buy Now | -48.6% | Keefe, Bruyette & Woods | Michael Brown64% | $81 → $80 | Reiterates | Market Perform → Market Perform | Get Alert |
05/26/2023 | Buy Now | -47.96% | JP Morgan | Kenneth Worthington60% | $85 → $81 | Maintains | Overweight | Get Alert |
05/26/2023 | Buy Now | -44.1% | Oppenheimer | Chris Kotowski83% | → $87 | Upgrade | Perform → Outperform | Get Alert |
05/26/2023 | Buy Now | -54.38% | Wells Fargo | Finian O'Shea64% | $73 → $71 | Maintains | Equal-Weight | Get Alert |
05/26/2023 | Buy Now | -48.6% | Keefe, Bruyette & Woods | Michael Brown64% | $81 → $80 | Maintains | Market Perform | Get Alert |
04/18/2023 | Buy Now | -47.96% | Keefe, Bruyette & Woods | Michael Brown64% | $85 → $81 | Maintains | Market Perform | Get Alert |
03/15/2023 | Buy Now | -45.39% | JP Morgan | Kenneth Worthington60% | → $85 | Upgrade | Neutral → Overweight | Get Alert |
02/09/2023 | Buy Now | -48.6% | Goldman Sachs | Alexander Blostein73% | $70 → $80 | Maintains | Neutral | Get Alert |
02/09/2023 | Buy Now | -49.88% | Morgan Stanley | Michael Cyprys69% | $72 → $78 | Maintains | Equal-Weight | Get Alert |
02/08/2023 | Buy Now | -45.39% | JP Morgan | Ken Worthington71% | $86 → $85 | Maintains | Neutral | Get Alert |
02/08/2023 | Buy Now | -51.81% | Wells Fargo | Finian O'Shea64% | $69 → $75 | Maintains | Equal-Weight | Get Alert |
01/24/2023 | Buy Now | -53.74% | Morgan Stanley | Michael Cyprys69% | $67 → $72 | Maintains | Equal-Weight | Get Alert |
01/11/2023 | Buy Now | -55.67% | Wells Fargo | Finian O'Shea64% | $65 → $69 | Maintains | Equal-Weight | Get Alert |
10/19/2022 | Buy Now | -56.31% | UBS | Adam Beatty38% | $75 → $68 | Maintains | Neutral | Get Alert |
10/19/2022 | Buy Now | -56.95% | Morgan Stanley | Michael Cyprys69% | $72 → $67 | Maintains | Equal-Weight | Get Alert |
08/09/2022 | Buy Now | -53.74% | Morgan Stanley | Michael Cyprys69% | $73 → $72 | Maintains | Equal-Weight | Get Alert |
08/09/2022 | Buy Now | -51.81% | UBS | Adam Beatty38% | $72 → $75 | Downgrade | Buy → Neutral | Get Alert |
07/19/2022 | Buy Now | -53.1% | Morgan Stanley | Michael Cyprys69% | $92 → $73 | Maintains | Equal-Weight | Get Alert |
07/13/2022 | Buy Now | -53.74% | Wells Fargo | Finian O'Shea64% | $74 → $72 | Maintains | Equal-Weight | Get Alert |
06/29/2022 | Buy Now | -51.17% | Goldman Sachs | Alexander Blostein73% | $85 → $76 | Maintains | Neutral | Get Alert |
06/01/2022 | Buy Now | -40.89% | Morgan Stanley | Michael Cyprys69% | $101 → $92 | Maintains | Equal-Weight | Get Alert |
04/20/2022 | Buy Now | -35.11% | Morgan Stanley | Michael Cyprys69% | $111 → $101 | Maintains | Equal-Weight | Get Alert |
04/19/2022 | Buy Now | -49.88% | Wells Fargo | Finian O'Shea64% | $95 → $78 | Maintains | Equal-Weight | Get Alert |
The latest price target for Hamilton Lane (NASDAQ:HLNE) was reported by Wells Fargo on March 20, 2025. The analyst firm set a price target for $152.00 expecting HLNE to fall to within 12 months (a possible -2.34% downside). 24 analyst firms have reported ratings in the last year.
The latest analyst rating for Hamilton Lane (NASDAQ:HLNE) was provided by Wells Fargo, and Hamilton Lane maintained their equal-weight rating.
The last upgrade for Hamilton Lane Inc happened on May 26, 2023 when Oppenheimer raised their price target to $87. Oppenheimer previously had a perform for Hamilton Lane Inc.
The last downgrade for Hamilton Lane Inc happened on January 6, 2025 when Goldman Sachs changed their price target from N/A to $139 for Hamilton Lane Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Hamilton Lane, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Hamilton Lane was filed on March 20, 2025 so you should expect the next rating to be made available sometime around March 20, 2026.
While ratings are subjective and will change, the latest Hamilton Lane (HLNE) rating was a maintained with a price target of $169.00 to $152.00. The current price Hamilton Lane (HLNE) is trading at is $155.64, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.